Literature DB >> 8459241

Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis.

I Ferrer1, T Tuñón, M T Serrano, R Casas, S Alcántara, M J Zújar, R M Rivera.   

Abstract

The morphology and distribution of local-circuit neurons (interneurons) were examined, by calbindin D-28k and parvalbumin immunocytochemistry, in the frontal cortex (area 8) in two patients with frontal lobe dementia of non-Alzheimer type associated with classical amyotrophic lateral sclerosis (ALS), and in seven normal cases. The density of calbindin D-28k immunoreactive cells was dramatically reduced in ALS patients, but the density of parvalbumin-immunoreactive neurons was preserved. Decreased density of calbindin D-28k-immunoreactive neurons, which are mainly located in the upper cortical layers, may interfere with the normal processing of cortico-cortical connections, whereas integrity of parvalbumin-immunoreactive cells may be associated with the preservation of the major inhibitory intracortical circuits in patients with frontal lobe dementia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8459241      PMCID: PMC1014857          DOI: 10.1136/jnnp.56.3.257

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  36 in total

1.  Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease.

Authors:  P R Hof; K Cox; W G Young; M R Celio; J Rogers; J H Morrison
Journal:  J Neuropathol Exp Neurol       Date:  1991-07       Impact factor: 3.685

2.  Selective staining of a population of parvalbumin-containing GABAergic neurons in the rat cerebral cortex by lectins with specific affinity for terminal N-acetylgalactosamine.

Authors:  T Kosaka; C W Heizmann
Journal:  Brain Res       Date:  1989-03-27       Impact factor: 3.252

3.  Parvalbumin-immunoreactive neurons in the human central nervous system are decreased in Alzheimer's disease.

Authors:  J Satoh; T Tabira; M Sano; H Nakayama; J Tateishi
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

4.  Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology.

Authors:  A Brun
Journal:  Arch Gerontol Geriatr       Date:  1987-09       Impact factor: 3.250

5.  Calcium binding proteins and neuropeptides as molecular markers of GABAergic interneurons in the cat visual cortex.

Authors:  H Demeulemeester; L Arckens; F Vandesande; G A Orban; C W Heizmann; R Pochet
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

6.  Loss of calbindin-28K immunoreactive neurones from the cortex in Alzheimer-type dementia.

Authors:  Y Ichimiya; P C Emson; C Q Mountjoy; D E Lawson; C W Heizmann
Journal:  Brain Res       Date:  1988-12-13       Impact factor: 3.252

7.  Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia.

Authors:  D S Knopman; A R Mastri; W H Frey; J H Sung; T Rustan
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

8.  Heterogeneity of GABAergic cells in cat visual cortex.

Authors:  H Demeulemeester; F Vandesande; G A Orban; C Brandon; J J Vanderhaeghen
Journal:  J Neurosci       Date:  1988-03       Impact factor: 6.167

9.  Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex.

Authors:  J DeFelipe; S H Hendry; E G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

10.  Dementia of frontal lobe type and motor neuron disease. A Golgi study of the frontal cortex.

Authors:  I Ferrer; C Roig; A Espino; G Peiro; X Matias Guiu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154

View more
  9 in total

1.  Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer's disease.

Authors:  Hisaaki Takahashi; Ivona Brasnjevic; Bart P F Rutten; Nicolien Van Der Kolk; Daniel P Perl; Constantin Bouras; Harry W M Steinbusch; Christoph Schmitz; Patrick R Hof; Dara L Dickstein
Journal:  Brain Struct Funct       Date:  2010-03-07       Impact factor: 3.270

Review 2.  A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia.

Authors:  Edward D Huey; Karen T Putnam; Jordan Grafman
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

3.  Dementia lacking distinctive histopathology: clinicopathological evaluation of 32 cases.

Authors:  P Giannakopoulos; P R Hof; C Bouras
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  Preconditioning, induced by sub-toxic dose of the neurotoxin L-BMAA, delays ALS progression in mice and prevents Na+/Ca2+ exchanger 3 downregulation.

Authors:  Serenella Anzilotti; Paola Brancaccio; Giuseppe Simeone; Valeria Valsecchi; Antonio Vinciguerra; Agnese Secondo; Tiziana Petrozziello; Natascia Guida; Rossana Sirabella; Ornella Cuomo; Pasquale Cepparulo; Andrè Herchuelz; Salvatore Amoroso; Gianfranco Di Renzo; Lucio Annunziato; Giuseppe Pignataro
Journal:  Cell Death Dis       Date:  2018-02-12       Impact factor: 8.469

Review 5.  Ionic Homeostasis Maintenance in ALS: Focus on New Therapeutic Targets.

Authors:  Rossana Sirabella; Valeria Valsecchi; Serenella Anzilotti; Ornella Cuomo; Antonio Vinciguerra; Pasquale Cepparulo; Paola Brancaccio; Natascia Guida; Nicolas Blondeau; Lorella M T Canzoniero; Cristina Franco; Salvatore Amoroso; Lucio Annunziato; Giuseppe Pignataro
Journal:  Front Neurosci       Date:  2018-08-07       Impact factor: 4.677

6.  A comparative perspective on minicolumns and inhibitory GABAergic interneurons in the neocortex.

Authors:  Mary Ann Raghanti; Muhammad A Spocter; Camilla Butti; Patrick R Hof; Chet C Sherwood
Journal:  Front Neuroanat       Date:  2010-02-05       Impact factor: 3.856

7.  MRI-guided histology of TDP-43 knock-in mice implicates parvalbumin interneuron loss, impaired neurogenesis and aberrant neurodevelopment in amyotrophic lateral sclerosis-frontotemporal dementia.

Authors:  Ziqiang Lin; Eugene Kim; Mohi Ahmed; Gang Han; Camilla Simmons; Yushi Redhead; Jack Bartlett; Luis Emiliano Pena Altamira; Isobel Callaghan; Matthew A White; Nisha Singh; Stephen Sawiak; Tara Spires-Jones; Anthony C Vernon; Michael P Coleman; Jeremy Green; Christopher Henstridge; Jeffrey S Davies; Diana Cash; Jemeen Sreedharan
Journal:  Brain Commun       Date:  2021-05-27

Review 8.  ALS Patient Stem Cells for Unveiling Disease Signatures of Motoneuron Susceptibility: Perspectives on the Deadly Mitochondria, ER Stress and Calcium Triad.

Authors:  Anjoscha Kaus; Dhruv Sareen
Journal:  Front Cell Neurosci       Date:  2015-11-19       Impact factor: 5.505

9.  Investigating perturbed pathway modules from gene expression data via structural equation models.

Authors:  Daniele Pepe; Mario Grassi
Journal:  BMC Bioinformatics       Date:  2014-05-06       Impact factor: 3.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.